Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomized, Open, Multicentre Study About the Effect of an Empirical Antibiotic Monotherapy With Meropenem (Meronem®) Versus a Combination Therapy With Moxifloxacin (Avalox®) on Organ Dysfunction in Patients With Severe Sepsis and Septic Shock

NCT00534287 is registered in ClinicalTrials.gov with Kompetenznetz Sepsis as lead sponsor.

NCT NCT00534287
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00534287 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomized, Open, Multicentre Study About the Effect of an Empirical Antibiotic Monotherapy With Meropenem (Meronem®) Versus a Combination Therapy With Moxifloxacin (Avalox®) on Organ Dysfunction in Patients With Severe Sepsis and Septic Shock
Lead sponsor
Kompetenznetz Sepsis
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2007
Completion date
June 30, 2010
Enrollment
600 (actual)
Sites
52

Conditions

As the registry lists them; a condition with its own page is linked.

septic shock, severe sepsis